Equity Research, Broker Reports, and media content on MERCK KGAA

  • Access the latest forecasts, broker valuations, multiples, and video content from the city about MERCK KGAA
  • See live updates from analysts, company announcements, and other news in a personalised/single dashboard

Research, Charts & Company Announcements

Research Tree provides access to ongoing research coverage, media content and regulatory news on MERCK KGAA. We currently have 6 research reports from 1 professional analysts.

Date Source Announcement
06Dec16 02:00 PRN Merck's Consumer Health Business Drives Consumer-Centric, Purposeful Innovation
06Dec16 09:00 PRN Merck's Consumer Health Business Drives Consumer-Centric, Purposeful Innovation
29Nov16 01:21 PRN FDA Accepts the Biologics License Application for Avelumab for the Treatment of Metastatic Merkel Cell Carcinoma for Priority Review
17Nov16 08:15 PRN With an Extended Fertility Technologies Portfolio Merck Now Covers All IVF Steps
14Nov16 01:00 PRN Merck KGaA, Darmstadt, Germany's Phase IIb ADDRESS II Results Confirm Potential of Atacicept as a Candidate Therapy for SLE
02Nov16 01:56 PRN Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeti
02Nov16 12:00 PRN Merck KGaA, Darmstadt, Germany, Presents Phase II Data on the Safety and Efficacy of Atacicept at the 2016 ACR/ARHP Annual Meeting
  • Frequency of research reports

     

  • Research reports on

    MERCK KGAA

  • Providers covering

    MERCK KGAA

Latest Content

View the latest research, videos, and podcasts for this company.